Overview

Pneumococcal Vaccines Early and in Combination

Status:
Completed

Trial end date:
2018-03-15

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether an early schedule of a combination of three doses of PHiD-CV and one dose of PCV13, is superior to three doses of either PCV13 or PHiD-CV.

Phase:

Phase 4

Details

Lead Sponsor:

Menzies School of Health Research

Treatments:

Heptavalent Pneumococcal Conjugate Vaccine
Vaccines